 |
|
| CRYPTOSPORIDIUM: FROM MOLECULES TO DISEASE
| |
| | |
|
|
To order this title, and for more information, click here
Edited By
R.C.A. Thompson
A. Armson
U.M. Ryan, Division of Veterinary and Biomedical Sciences, Murdoch University, Murdoch, WA, Australia
Description
In the relatively short period since Cryptosporidium was recognised as a human pathogen, and that it could be transmitted in
water as well as directly between animals and people, it has been the subject of intense investigations. Its status as an opportunistic
pathogen, especially in AIDS patients, and the lack of effective anti-cryptosporidial drugs have served to emphasise the public health
importance of this organism. This has to some extent overshadowed the fact that Cryptosporidium is also an important pathogen
of domestic animals and wildlife.
In recent years, the application of molecular biology and culture techniques have had an enormous
impact on our understanding of the aetiological agents of cryptosporidial infections and our ability to study the causative agents in
the laboratory. As a consequence, a wealth of information and novel data has been produced during the last 3-4 years, particularly in
the areas of taxonomy, biology, pathogenesis, epidemiology - particularly zoonotic and water borne transmission, and treatment.
It
is thus very timely to bring together in this book the international research community involved to review the major advances in research
and identify the important research priorities for the future, thus enabling as wide an audience as possible to benefit from and share
in this comprehensive look at Cryptosporidium and cryptosporidiosis.
Audience
Parasitologists, microbiologists, veterinarians, physicians, gastroenterologists, water quality professionals.
Contents
Preface (A. Thompson). Introduction: Cryptosporidium: from molecules to disease (G. Meinke).
Cryptosporidiosis - Aetiology, Infectivity
and Pathogenesis.
Cryptosporidium: they probably taste like chicken (S.J. Upton). Cryptosporidium: from molecules
to disease (R. Fayer). Cryptosporidium parvum: infectivity, pathogenesis and the host-parasite relationship (C.L. Chappell,
P.C. Okhuysen et al.). What is the clinical and zoonotic significance of cryptosporidiosis in domestic animals and wildlife
(M.E. Olson, B.J. Ralston et al.).
Extended Abstracts.
Control of Cryptosporidium parvum infection
and the role of IL-4 in two strains of inbred mice (C.A. Notley, S.A.C. Mcdonald et al.). Human peripheral CD8+CD103+
T-lymphocyte transmigration through inverted Cryptosporidium parvum sporozoite infected HCT-8 cell monolayers (G. Gargala, A.
Delaunay et al.). Cryptosporidium parvum volunteer study: infectivity and immunity (C.L. Chappell, P.C. Okhuysen et
al.). Transmission of human genotype 1 Cryptosporidium parvum into lambs (M. Giles, D.C. Warhurs et al.). A longitudinal
study of Cryptosporidium prevalence and its impact on performance in feedlot cattle (B.J. Ralston, M.E. Olson et al.).
Identification and characterisation of the antigenic CPA135 protein (F. Tosini, A. Agnoli et al.). A permanent method for detecting
Cryptosporidium parvum life cycle stages in in vitro culture (H.V. Smith, R.A. Nichols et al.).
Successful
cultivation of Cryptosporidium reveals previously undescribed Gregarino-like developmental stages (N. Hijjawi, B.P. Meloni et
al.).
Epidemiology and species differentiation.
Cryptosporidium as a public health challenge (R.M. Chalmers).
The zoonotic potential of Cyptosporidium (R.C.A. Thompson). Molecular epidemiology of human cryptosporidiosis (L. Xiao, C. Bern et al.). Molecular characterisation and taxonomy of Cryptosporidium (U.M. Ryan).
Extended Abstracts.
Antigenic differences in Cryptosporidium parvum oocysts: the "Iowa strain" enigma (A. Ronald, S. Birrell et al.). Antigenic
analysis of Cryptosporidium parvum isolates of human and animal origin (A. Ronald, J.E. O'Grady, H.V. Smith). Typing of Cryptosporidium
parvum oocysts using phage-display technology (C. Lima, H.V. Smith et al.). High resolution genotyping of Cryptosporidium
by mutation scanning (A. El-Osta, Y. Zhu et al.). Evaluation of oocyst DNA extraction methods using real-time PCR (P. Monis,
A. Keegan et al.). Differentiation of Cryptosporidium parvum subtypes by a novel microsatelite-telomere PCR with page
(S.A. Blasdall, J.E. Ongerth, N. Ashbolt). Genotypic variation of Cryptosporidium organisms recovered from persons living in
Kenya, Malawi, Vietnam and Brazil (W. Gatei, C.A. Hart et al.). Epidemiological surveys of cryptosporidiosis in Thai orphans
(M. Mungthin, T. Naaglor et al.). Cryptosporidium and Cyclospora-associated diarrhea in Kathmandu, Nepal (K.
Ono, K. Kimura et al.). Ecology of zoonotic cryptosporidiosis in watersheds containing cattle farming operations (T.K. Graczyk,
C.J. Shiff et al.). Identifying variation among human, animal and environmental isolates of Cryptosporidium (R.M. Chalmers). Cryptosporidium in eastern grey kangaroos Macropus giganteus (M.L. Power, M.B. Slade et al.).
Viability
and infectivity.
Detection of infectious Cryptosporidium parvum oocysts in environmental water samples (G.D. Di Giovanni,
R. Aboytes). Measuring inactivation of Cryptosporidium parvum by in vitro cell culture (P.A. Rochelle, A.A Mofidi et
al.). In vitro cultivation and development of Cryptosporidium in cell culture (N. Hijjawi).
Extended
Abstracts.
The use of cell culture and real-time PCR to assess disinfection of Cryptosporidium parvum (A. Keegan, S.
Gelonese et al.). Inactivation of Cryptosporidium parvum oocysts by low pressure UV-light (P. Karanis, D. Schoenen,
O. Hoyer). Detection of viable oocysts of Cryptosporidium parvum by nucleic acid sequence-based amplification (NASBA) (C.J.
Lowery, J.E. Moore et al.). Flow cytometric evaluation of Cryptosporidium parvum oocyst viability (A. Delaunaya, G.
Gargalaa et al.).
Cryptosporidium and the environment.
The public health significance of Cryptosporidium
in the environment (P.T. Monis, R.M. Chalmers). Assessing variables in disinfection parameters of Cryptosporidium parvum oocysts
(M.M. Marshall). Detection of Cryptosporidium oocysts in water matrices (F.W. Schaefer III). Microbiological health criteria
for Cryptosporidium (C. Ferguson, G. Medema et al.). Case-control studies of sporadic Cryptosporidiosis in Melbourne
and Adelaide (B.R. Robertson, C.K. Fairley et al.). The DWI licensed inter-laboratory Cryptosporidium proficiency scheme
(CRYPTS) (H.V. Smith, B.M. Campbell, J. Peet).
Extended Abstracts.
Detection of Cryptosporidium spp. via fluorescent in situ hybridisation: novel approaches of background reduction and signal enhancement (M. Dorsch, D.A. Veal). The risk of Cryptosporidium
to Sydney's drinking water supply (P. Cox, P. Hawkins et al.). Outbreak of waterborne Cryptosporidiosis at North Battleford,
SK, Canada (P. Wallis, N. Bounsombath et al.). Event sampling for Cryptosporidium and Giardia in
South Australian
water sources (S. Hayes, P. Dobson et al.). Drinking water regulations for Cryptosporidum in England and Wales (D.
Drury, A. Lloyd). Why Cryptosporidium research for large water supplies: investigations in the Lake Mornos, the big water reservoir
of Greater Athens, Greece (P. Karanis, C. Papadopoulou et al.). NATA accreditation of laboratories testing water for the presence
of parasitic protozoa (T.G. Orlova). Use of ferric sulfate flocculation method for the recovery of Cryptosporidium oocysts from
drinking water (P. Karanis, A. Kimura). A sensitive, semi-quantitative direct PCR-RFLP assay for simultaneous detection of five Cryptosporidium
species in treated drinking waters and mineral waters (R.A.B. Nichols, C.A. Paton et al.). The incidence of Cryptosporidium
and Giardia in private water supplies in the United Kingdom (J. Watkins, D. Drury). The problem with Cryptosporidium in
swimming pools (G. Nichols, R. Chalmers et al.). Cryptosporidium parvum oocyst recovery using immunomagnetisable separation
(C.A. Paton, D.E. Kelsey et al.). Significance of enhanced morphological detection of Cryptosporidium sp. oocysts in
water concentrates using DAPI and immunofluorescence microscopy (H.V. Smith, B.M. Campbell et al.). Surveillance of Cryptosporidiosis:
progressive approaches (G. Nichols, J. McLauchlin et al.). Cryptosporidium and the environment - overview and summary (R.M.
Chalmers, P. Monis).
Cryptosporidium - chemotherapy.
A review of chemotherapeutic approaches to the treatment
of Cryptosporidium (A. Armson, J.A. Reynoldson, R.C.A. Thompson).
Extended Abstracts.
An examination of the
activity of the dinitroanilines on Cryptosporidium parvum using in vitro, in vivo and target expression methods
(A. Armson, R.C.A. Thompson et al.). Nitazoxanide in the treatment of cryptosporidiosis (J.F. Rossignol, A. Youb et al.).
The application of quantitative-PCR for high throughput screening of novel compounds against Cryptosporidium parvum in vitro
and their subsequent IC50 determination (L. Pallant, L. Macdonald et al.). Development of a standard method to recover
protozoan parasites from soft fruit and salad vegetables (C.A. Paton, N. Wilkinson et al.). How safe is drinking water in primary
schools? (U. Chukohtuad, V. Suphiphat).
Synthesis.
Facilitators: (P. O'Donoghue, S. Upton et al.).
| Bibliographic details |
Hardbound, 468 pages, publication date: DEC-2003
ISBN-13: 978-0-444-51351-9
ISBN-10: 0-444-51351-5
Imprint: ELSEVIER
|
| Price and Ordering |
Price:
GBP 115
USD 185
EUR 143
|  |
Books and book related electronic products are priced in US dollars (USD), euro (EUR), and Great Britain Pounds (GBP). USD prices apply to the Americas and Asia Pacific. EUR prices apply in Europe and the Middle East. GBP prices apply to the UK and all other countries.
|
See also information about conditions of sale & ordering procedures, and links to our regional sales offices.
|
092/941
Last update: 30 Nov 2009
|
|
| |
| | |
|
|
| |
Home | Elsevier Sites | Privacy Policy | Terms and Conditions | Feedback | Site Map | A Reed Elsevier Company